Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Restructuring Costs (2024 - 2026)

Updated

Genmab A's Restructuring Costs was -$32 million in the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Restructuring Costs (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Genmab A's Restructuring Costs was -$120 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$185 million.

  • In earlier years, Restructuring Costs was -$43 million in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Restructuring Costs since the quarter ended Sep 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -10.00 Mn
Jun 30, 2026 -32.00 Mn
Mar 31, 2026 -45.00 Mn
Dec 31, 2024 -43.00 Mn
Sep 30, 2024 -3.00 Mn
Jun 30, 2024 -25.00 Mn
API Access

Genmab A Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GMAB&period=max&api_key=YOUR_API_KEY